StockNews.com Upgrades REGENXBIO (NASDAQ:RGNX) to “Hold”
REGENXBIO (NASDAQ:RGNX – Get Free Report) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Friday. Several other research analysts have also commented on the company. Barclays lowered their price target on REGENXBIO from $55.00 to $50.00 and set an “overweight” rating for […]
More Stories
Invesco Municipal Strategic Income ETF (BATS:IMSI) Announces Dividend Increase – $0.17 Per Share
Invesco Municipal Strategic Income ETF (BATS:IMSI – Get Free Report) declared a dividend on Friday, September 20th, NASDAQ reports. Stockholders...
Southern Cross Electrical Engineering Limited (ASX:SXE) Plans Dividend Increase – $0.05 Per Share
Southern Cross Electrical Engineering Limited (ASX:SXE – Get Free Report) announced a final dividend on Thursday, September 19th, MarketIndexAU reports....
Regency Centers (NASDAQ:REG) Updates FY 2024 Earnings Guidance
Regency Centers (NASDAQ:REG – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The...
Steel Dynamics (NASDAQ:STLD) Issues Q3 2024 Earnings Guidance
Steel Dynamics (NASDAQ:STLD – Get Free Report) updated its third quarter 2024 earnings guidance on Friday. The company provided EPS...
Corning (NYSE:GLW) Issues Q3 2024 Earnings Guidance
Corning (NYSE:GLW – Get Free Report) issued an update on its third quarter 2024 earnings guidance on Thursday morning. The...
Brokerages Set América Móvil, S.A.B. de C.V. (NYSE:AMX) PT at $21.39
Shares of América Móvil, S.A.B. de C.V. (NYSE:AMX – Get Free Report) have been assigned an average recommendation of “Moderate...